Janus Henderson Group
AGIO icon

Janus Henderson Group’s Agios Pharmaceuticals AGIO Stock Holding History

Janus Henderson Group’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$805K Hold
23,797
– – ﹤0.01% 1784
2025
Q4 		$648K Hold
23,797
– – ﹤0.01% 1898
2025
Q3 		$955K Hold
23,797
– – ﹤0.01% 1690
2025
Q2 		$791K Hold
23,797
– – ﹤0.01% 1723
2025
Q1 		$721K Hold
23,797
– – ﹤0.01% 1780
2024
Q4 		$782K Sell
23,797
-2,100
-8% -$98.7K ﹤0.01% 1809
2024
Q3 		$1.15M Hold
25,897
– – ﹤0.01% 1594
2024
Q2 		$1.12M Sell
25,897
-3,684
-12% -$133K ﹤0.01% 1569
2024
Q1 		$864K Buy
29,581
+7
+0% +$187 ﹤0.01% 1714
2023
Q4 		$659K Sell
29,574
-41
-0.1% -$919 ﹤0.01% 1866
2023
Q3 		$733K Buy
29,615
+3
+0% +$79 ﹤0.01% 1723
2023
Q2 		$839K Sell
29,612
-35
-0.1% -$871 ﹤0.01% 1692
2023
Q1 		$681K Buy
29,647
+21,058
+245% +$559K ﹤0.01% 1847
2022
Q4 		$241K Buy
+8,589
New +$242K ﹤0.01% 2086
2022
Q2 		– Sell
-8,584
Closed -$250K – 2591
2022
Q1 		$250K Sell
8,584
-4,110
-32% -$126K ﹤0.01% 2327
2021
Q4 		$418K Buy
12,694
+6,374
+101% +$257K ﹤0.01% 2000
2021
Q3 		$292K Buy
+6,320
New +$305K ﹤0.01% 1908
2018
Q4 		– Sell
-24,800
Closed -$1.91M – 1333
2018
Q3 		$1.91M Sell
24,800
-7,600
-23% -$611K ﹤0.01% 1187
2018
Q2 		$2.73M Buy
32,400
+7,400
+30% +$645K ﹤0.01% 1122
2018
Q1 		$2.04M Sell
25,000
-460,239
-95% -$35.6M ﹤0.01% 1161
2017
Q4 		$27.7M Buy
485,239
+96,703
+25% +$6.08M 0.02% 673
2017
Q3 		$25.9M Sell
388,536
-8,418
-2% -$506K 0.02% 677
2017
Q2 		$20.4M Buy
+396,954
New +$20.3M 0.01% 739

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return

Janus Henderson Group's AGIO Position: Q1 2026 in Review

Janus Henderson Group held its Agios Pharmaceuticals (AGIO) position steady in Q1 2026 at 23,797 shares worth $805K. The position accounts for ﹤0.01% of the portfolio, ranked #1784.

Janus Henderson Group first reported a position in AGIO in Q2 2017 and has held it in 23 quarters since. The position peaked at $27.7M in Q4 2017. 234 funds tracked by Wall St. Rank hold AGIO as of Q1 2026.

  • Janus Henderson Group held 23,797 shares of Agios Pharmaceuticals worth $805K as of Q1 2026.
  • Janus Henderson Group left its Agios Pharmaceuticals share count unchanged in Q1 2026.
  • Agios Pharmaceuticals made up ﹤0.01% of Janus Henderson Group's portfolio in Q1 2026, its #1784 holding.
  • Janus Henderson Group first reported a position in Agios Pharmaceuticals in Q2 2017 and has held it in 23 quarters since.
  • Janus Henderson Group's Agios Pharmaceuticals position peaked at $27.7M in Q4 2017.
  • 234 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q1 2026.

Based on Janus Henderson Group's 13F filing for Q1 2026, filed 15 May 2026.